Partial Cystectomy for Muscle Invasive Urothelial Carcinoma of the Bladder: A Contemporary Review of the M. D. Anderson Cancer Center Experience
- 1 June 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 175 (6), 2058-2062
- https://doi.org/10.1016/s0022-5347(06)00322-3
Abstract
Partial cystectomy is a surgical option for select patients diagnosed with urothelial carcinoma. We review our experience with partial cystectomy for muscle invasive urothelial carcinoma to assess local control and survival rates. From 1982 to 2003 a total of 37 patients with muscle invasive urothelial carcinoma underwent partial cystectomy with curative intent. Reviewed data included history of superficial tumors, presence of variant histology, tumor location, clinical stage, pathological stage, presence of carcinoma in situ, adjuvant therapy and disease status. The 5-year overall, disease specific and recurrence-free survival rates were 67%, 87% and 39%, respectively. Mean followup was 72.6 months (range 6 to 217). Of the 37 patients 19 (51%) did not have tumor recurrence, 9 (24%) had superficial recurrence in the bladder that was treated successfully and 9 (24%) had recurrence with advanced disease. A total of 24 patients (65%) had an intact bladder with no evidence of disease after a median of 53 months. There were 6 patients (16%) who died of bladder cancer, 3 of whom died of late recurrence of muscle invasive cancer (41, 44 and 138 months after partial cystectomy). On multivariate analysis higher pathological stage (HR 3.4, p = 0.04) was associated with shorter recurrence-free survival. A history of superficial tumors (p <0.01) and clinical stage (p = 0.01) was associated with advanced recurrence-free survival. The use of adjuvant chemotherapy (HR 0.18, p = 0.03) was associated with prolonged advanced recurrence-free survival, however adjuvant chemotherapy did not impact overall survival. Partial cystectomy provides adequate local control of muscle invasive bladder cancer in select patients. Because late recurrence is not uncommon and is potentially life threatening, lifelong followup with cystoscopy is recommended.Keywords
This publication has 16 references indexed in Scilit:
- Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.Journal of Clinical Oncology, 1998
- FEASIBILITY OF TRANSURETHRAL RESECTION FOR MUSCLE INFILTRATING CARCINOMA OF THE BLADDER: LONG-TERM FOLLOWUP OF A PROSPECTIVE STUDYJournal of Urology, 1998
- Partial cystectomy for invasive bladder cancerJournal of Surgical Oncology, 1995
- PARTIAL CYSTECTOMYUrologic Clinics of North America, 1992
- Partial Cystectomy for Transitional Cell Carcinoma of the BladderScandinavian Journal of Urology and Nephrology, 1984
- Partial cystectomy: Can it be incorporated into integrated therapy program?Urology, 1983
- Partial Cystectomy in the Treatment of Transitional Cell Carcinoma of the BladderJournal of Urology, 1978
- Complications of Partial Cystectomy in Patients with High Grade Bladder CarcinomaJournal of Urology, 1977
- Partial Cystectomy in the Treatment of Primary and Secondary Carcinoma of the BladderJournal of Urology, 1976
- Segmental Resection for Carcinoma of the Bladder: Review of 102 PatientsJournal of Urology, 1973